Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur F Kavanaugh

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Clinics in Chest Medicine|March 18, 2006
Biologic therapies for the treatment of asthmaAmy L Wagelie-Steffen, Arthur F Kavanaugh, Stephen I Wasserman
The American Journal of Medicine|May 3, 2011
Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's diseaseArthur F Kavanaugh, Lloyd F Mayer, John J Cush, et al.
RMD Open|April 20, 2018
Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III studyDésirée van der Heijde, Jürgen Braun, Martin Rudwaleit, et al.
Arthritis and Rheumatism|December 2, 2005
Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et alTheodore Pincus, Yusuf Yazici, Hasan Yazici, et al.
The Journal of Rheumatology|July 9, 2008
Initiative for quality in psoriasis and psoriatic arthritisWolf-Henning Boehncke, Ade Adebajo, Alberto Cauli, et al.
RMD Open|August 6, 2016
Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritisRoy M Fleischmann, Tom W J Huizinga, Arthur F Kavanaugh, et al.
Arthritis and Rheumatism|May 18, 2004
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trialEdward C Keystone, Arthur F Kavanaugh, John T Sharp, et al.
Arthritis and Rheumatism|April 13, 2004
Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serologyAllan S Wiik, Thomas P Gordon, Arthur F Kavanaugh, et al.
Arthritis and Rheumatism|December 31, 2005
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentFerdinand C Breedveld, Michael H Weisman, Arthur F Kavanaugh, et al.
Journal of Evaluation in Clinical Practice|August 21, 2010
Predictors of doctor-rated and patient-rated gout severity: gout impact scales improve assessmentAndrew J Sarkin, Ashley E Levack, Marian M Shieh, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinics in Chest Medicine|March 18, 2006
Biologic therapies for the treatment of asthmaAmy L Wagelie-Steffen, Arthur F Kavanaugh, Stephen I Wasserman
The American Journal of Medicine|May 3, 2011
Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's diseaseArthur F Kavanaugh, Lloyd F Mayer, John J Cush, et al.
RMD Open|April 20, 2018
Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III studyDésirée van der Heijde, Jürgen Braun, Martin Rudwaleit, et al.
Arthritis and Rheumatism|December 2, 2005
Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et alTheodore Pincus, Yusuf Yazici, Hasan Yazici, et al.
The Journal of Rheumatology|July 9, 2008
Initiative for quality in psoriasis and psoriatic arthritisWolf-Henning Boehncke, Ade Adebajo, Alberto Cauli, et al.
RMD Open|August 6, 2016
Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritisRoy M Fleischmann, Tom W J Huizinga, Arthur F Kavanaugh, et al.
Arthritis and Rheumatism|May 18, 2004
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trialEdward C Keystone, Arthur F Kavanaugh, John T Sharp, et al.
Arthritis and Rheumatism|April 13, 2004
Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serologyAllan S Wiik, Thomas P Gordon, Arthur F Kavanaugh, et al.
Arthritis and Rheumatism|December 31, 2005
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentFerdinand C Breedveld, Michael H Weisman, Arthur F Kavanaugh, et al.
Journal of Evaluation in Clinical Practice|August 21, 2010
Predictors of doctor-rated and patient-rated gout severity: gout impact scales improve assessmentAndrew J Sarkin, Ashley E Levack, Marian M Shieh, et al.
Pageof 4